Clinical Trial Update: AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial for AlloStim in-situ vaccine in pre-treated metastatic colorectal cancer has been withdrawn from both Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AlloStim (allogeneic immunotherapy)

Snippet

Sponsor: Mirror Biologics, Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2, Phase 3 | Status: WITHDRAWN